Imperial Valley News Center
- Written by Peter Bracke and Reggie Kumar
Los Angeles, California - Pembrolizumab, a drug that has already been proven to extend the lives of people with advanced melanoma, has now been approved by the U.S. Food and Drug Administration to treat advanced non-small cell lung cancer. The study, the largest published research to date using immunotherapy to treat lung cancer, was conducted at UCLA and 29 other sites in the U.S., Europe and Australia.
- Written by Shaun Mason
Los Angeles, California - Our smartphones, tablets, computers and biosensors all have improved because of the rapidly increasing efficiency of semiconductors.
- Written by Elaine Schmidt
Los Angeles, California - diet high in processed fructose sabotages rats’ brains’ ability to heal after head trauma, UCLA neuroscientists report.
- Written by Reggie Kumar
Los Angeles, California - A study by UCLA researchers shows that going to churches to promote testing for chronic hepatitis B, which is associated with liver cancer and other liver diseases, can lead to improved testing rates among Korean Americans.
- Written by Emily Gersema
Los Angeles, California - Treating 5 percent of all hepatitis C patients with the latest drugs would be more effective at reducing infections and health care costs than the current approach, a new study shows.
- Written by Robert Perkins
Los Angeles, California - Researchers at USC and Wake Forest Baptist Medical Center have developed a brain prosthesis that is designed to help individuals suffering from memory loss.
Page 1586 of 2510